The development of drug resistance following treatment with chemotherapeutic agents such
The development of drug resistance following treatment with chemotherapeutic agents such as cisplatin (cis) and paclitaxel (pax) contributes to high morbidity and mortality in ovarian cancers. adequate to inhibit proliferation and sluggish tumour development [11]. Nevertheless, Brn-3b can be induced pursuing treatment with chemotherapeutic medicines such as for example cisplatin and high amounts also confer … [Read more…]